avatar

DINA MULYANTI

Universitas Islam Bandung S1 - Farmasi SINTA ID : 6728963
566
SINTA Score Overall
280
SINTA Score 3Yr
566
Affil Score
280
Affil Score 3Yr
Latest number of publications
Aspek Bioteknologi dan Kehalalan Kopi Luwak serta Korelasi Manfaatnya untuk Kesehatan
UPT Publikasi Ilmiah Unisba Jurnal Riset Farmasi Volume 2, No. 1, Juli 2022, Jurnal Riset Farmasi (JRF)69-76
Author Order : 2 of 2
Rezza Marcella; Dina Mulyanti
2022 DOI: 10.29313/jrf.v2i1.849 Accred : Sinta 5
Kajian Pengembangan Sediaan Nanokapsul Terkonjugasi Asam Folat untuk Penghantaran Tertarget Agen Sitotoksik pada Terapi Kanker
UNISBA Press Bandung Conference Series: Pharmacy Vol. 2 No. 2 (2022): Bandung Conference Series: Pharmacy281-290
Author Order : 3 of 3
Neneng Alifia Nur Fauziah; Sani Ega Priani; Dina Mulyanti
2022 DOI: 10.29313/bcsp.v2i2.4137 Accred : Unknown
Studi Literatur Titik Kritis Kehalalan pada Alat Kesehatan
UNISBA Press Bandung Conference Series: Pharmacy Vol. 2 No. 2 (2022): Bandung Conference Series: Pharmacy385-391
Author Order : 2 of 3
Nurul Azmi Firdiyani; Dina Mulyanti; Anan Suparman
2022 DOI: 10.29313/bcsp.v2i2.4217 Accred : Unknown
Kajian Potensi Biomarker Molekuler untuk Deteksi Dini Kanker Serviks, Hati dan Nasofaring serta Prospektif Kit Diagnostiknya
UNISBA Press Bandung Conference Series: Pharmacy Vol. 2 No. 2 (2022): Bandung Conference Series: Pharmacy489-498
Author Order : 2 of 2
Siti Roisah; Dina Mulyanti
2022 DOI: 10.29313/bcsp.v2i2.4308 Accred : Unknown
Potensi MUC1 sebagai Target Imunoterapi Triple-Negative Breast Cancer (TNBC)
UNISBA Press Bandung Conference Series: Pharmacy Vol. 2 No. 2 (2022): Bandung Conference Series: Pharmacy499-502
Author Order : 2 of 2
Aisyah Qanitah; Dina Mulyanti
2022 DOI: 10.29313/bcsp.v2i2.4311 Accred : Unknown
Simulasi Pengembangan Obat Baru pada Senyawa Apigenin, Curcumin, Fisetin, Naringenin dan Silibinin terhadap Protein Target Phosphoinositide 3-Kinases (PI3-Ks) secara In Silico
UNISBA Press Bandung Conference Series: Pharmacy Vol. 2 No. 2 (2022): Bandung Conference Series: Pharmacy660-670
Author Order : 3 of 4
Sylvie Kurniasih; Ridwan Wijaya; Dina Mulyanti; Taufik Muhammad Fakih
2022 DOI: 10.29313/bcsp.v2i2.4403 Accred : Unknown
Studi Bioinformatik Identifikasi Epitop Sel-B Virus SARS-CoV-2 Varian B.1.1.529 terhadap Reseptor Imun TLR5 (Toll-like Receptor 5) dalam Perancangan Vaksin Berbasis Peptida
UNISBA Press Bandung Conference Series: Pharmacy Vol. 2 No. 2 (2022): Bandung Conference Series: Pharmacy738-745
Author Order : 2 of 3
Annisaa Maryati Hasni; Dina Mulyanti; Diar Herawati
2022 DOI: 10.29313/bcsp.v2i2.4457 Accred : Unknown
Studi Literatur Potensi Pengembangan Produk Biosimilar untuk Pengobatan Penyakit Tidak Menular di Indonesia
UNISBA Press Bandung Conference Series: Pharmacy Vol. 2 No. 2 (2022): Bandung Conference Series: Pharmacy822-829
Author Order : 2 of 2
Gizca Ratna Tazkia; Dina Mulyanti
2022 DOI: 10.29313/bcsp.v2i2.4559 Accred : Unknown
Uji Aktivitas In Silico Senyawa Turunan Flavonoid sebagai Antiviral (HIV)
UNISBA Press Bandung Conference Series: Pharmacy Vol. 2 No. 2 (2022): Bandung Conference Series: Pharmacy950-957
Author Order : 3 of 3
Arini Nabila Putri; Taufik Muhammad Fakih; Dina Mulyanti
2022 DOI: 10.29313/bcsp.v2i2.4699 Accred : Unknown
Kajian Potensi Penyebaran Mikroorganisme Patogen Penyebab ISPA dan Diare Berdasarkan Kondisi Geografis dan Demografis Wilayah Indonesia
UNISBA Press Bandung Conference Series: Pharmacy Vol. 2 No. 2 (2022): Bandung Conference Series: Pharmacy884-890
Author Order : 2 of 3
Erica Yola Pramana Putri; Dina Mulyanti; Evi Umayah
2022 DOI: 10.29313/bcsp.v2i2.4676 Accred : Unknown
View more ...
Get More with SINTA Insight
Go to Insight

Summary

Article Quartile
Research Output
  Scopus GScholar WOS
Article 6 53 3
Citation 21 314 13
Cited Document 3 32 2
H-Index 2 10 2
i10-Index 1 10 1
G-Index 1 1 1
Get More with SINTA Insight

Go to Insight